glp 1 agonists vs sglt2 inhibitors GLP-1 Receptor Agonist Therapy With and Without in Patients With Type 2 Diabetes Disparities in SGLT2 Inhibitor or
Description
Dispensing of glucagon-like peptide-1 receptor agonists to adolescents and young adults, 2020-2023
Incretin hormones: revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity
But researchers caution that the study, though large, was not the sort of controlled clinical trial needed to confirm that GLP-1 drugs offer a safe and effective way to treat addiction
To counter such impacts, some companies are exploring ways that GLP-1RA drugs could complement their existing solutions
